Literature DB >> 6353131

Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies.

A I Tauber, N Borregaard, E Simons, J Wright.   

Abstract

Chronic granulomatous disease (CGD) is an inherited disorder of host defense due to the inability of the phagocyte to generate toxic oxygen metabolites upon appropriate stimulation. The disorder is heterogeneous even within the confines of a defective respiratory burst oxidase function, and may arise from a biochemical lesion at either the receptor, the activating pathways or the enzyme level. The identification of defects in plasma membrane depolarization, missing cytochrome and abnormal enzymatic function has yielded new insights into the pathophysiologic basis of CGD. A classification of this syndrome based on more precise biochemical criteria is proposed, which defines the disease as distinct from other associated enzymopathies with similar pathology and emphasizes the metabolic basis of the pathophysiologic defect in phagocyte function. Review of the clinical manifestations, pathogenic organisms and natural course of the disease, emphasizes the critical role of the oxidative metabolism of the normal neutrophil and offers a perspective on oxygen free radical biochemistry in the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6353131

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  47 in total

1.  Relapsing Salmonella enteritidis infection in a young adult male with chronic granulomatous disease.

Authors:  A F Safe; R T Maxwell; A J Howard; R C Garcia
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

2.  Brazilian report on primary immunodeficiencies in children: 166 cases studied over a follow-up time of 15 years.

Authors:  A S Grumach; A J Duarte; R Bellinati-Pires; A C Pastorino; C M Jacob; C L Diogo; A Condino-Neto; M Kirschfink; M M Carneiro-Sampaio
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

3.  Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

Authors:  R A Ezekowitz; S H Orkin; P E Newburger
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

4.  Pulmonary aspergillosis appearing as chronic nodular disease in chronic granulomatous disease.

Authors:  M J Chusid; J R Sty; R G Wells
Journal:  Pediatr Radiol       Date:  1988

5.  Coregulation of NADPH oxidase activation and phosphorylation of a 48-kD protein(s) by a cytosolic factor defective in autosomal recessive chronic granulomatous disease.

Authors:  S E Caldwell; C E McCall; C L Hendricks; P A Leone; D A Bass; L C McPhail
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

6.  Augmentation of oxidant injury to human pulmonary epithelial cells by the Pseudomonas aeruginosa siderophore pyochelin.

Authors:  B E Britigan; G T Rasmussen; C D Cox
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

7.  A missense mutation in the neutrophil cytochrome b heavy chain in cytochrome-positive X-linked chronic granulomatous disease.

Authors:  M C Dinauer; J T Curnutte; H Rosen; S H Orkin
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

8.  Superoxide generation is inhibited by phospholipase A2 inhibitors. Role for phospholipase A2 in the activation of the NADPH oxidase.

Authors:  L M Henderson; J B Chappell; O T Jones
Journal:  Biochem J       Date:  1989-11-15       Impact factor: 3.857

Review 9.  Osteomyelitis. Common causes and treatment recommendations.

Authors:  D R Dirschl; L C Almekinders
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

10.  Composition of partially purified NADPH oxidase from pig neutrophils.

Authors:  P Bellavite; O T Jones; A R Cross; E Papini; F Rossi
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.